Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uekama

Showing results (21-30 of 249) with videos related to

Pageof 25
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 1, 1979
[Soluble complex formation of 6-ethyl-2,3,6,9-tetrahydro-3-methyl-2,9-dioxothiazolo-[5,4-f]quinoline-8-carboxylic acid (tioxacin) with aliphatic amines (author's transl)]K Uekama, F Hirayama, N Takasugi
Gan|December 1, 1970
Promotion by DNA of the photoinduced radical production from 4-nitroquinoline 1-oxide in aqueous medium at 77 degrees K and its mechanismT Okano, A Takadate, K Uekama
The Journal of Pharmacy and Pharmacology|January 1, 1996
In-vitro evaluation of biphenylyl acetic acid-beta-cyclodextrin conjugates as colon-targeting prodrugs: drug release behaviour in rat biological mediaF Hirayama, K Minami, K Uekama
The Journal of Pharmacy and Pharmacology|June 1, 1994
In-vivo and in-vitro evaluations of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcelluloses in dogsZ Wang, F Hirayama, K Uekama
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 1, 1980
[Model analyses of interfacial transfer and absorption behaviors of drugs following dissolution: approach to evaluation procedure of bioavailability (author's transl)]K Uekama, J Fujisaki, F Hirayama
Journal of Pharmaceutical Sciences|June 11, 1998
Colon-specific drug delivery based on a cyclodextrin prodrug: release behavior of biphenylylacetic acid from its cyclodextrin conjugates in rat intestinal tracts after oral administrationK Minami, F Hirayama, K Uekama
Journal of Medicinal Chemistry|August 15, 1997
6A-O-[(4-biphenylyl)acetyl]-alpha-, -beta-, and -gamma-cyclodextrins and 6A-deoxy-6A-[[(4-biphenylyl)acetyl]amino]-alpha-, -beta-, and -gamma-cyclodextrins: potential prodrugs for colon-specific deliveryK Uekama, K Minami, F Hirayama
Chemical & Pharmaceutical Bulletin|June 1, 1974
Methanesulfonic acid derivative of p,p'-diaminodiphenylsulfone. II. Pharmacokinetics and availability of parental drug in rabbitY Kurono, K Ikeda, K Uekama
Chemical & Pharmaceutical Bulletin|March 1, 1997
Varying effects of cyclodextrin derivatives on aggregation and thermal behavior of insulin in aqueous solutionK Tokihiro, T Irie, K Uekama
Pharmaceutical Research|December 1, 1994
Effect of 2-hydroxypropyl-beta-cyclodextrin on crystallization and polymorphic transition of nifedipine in solid stateF Hirayama, Z Wang, K Uekama
Pageof 25

Showing results (21-30 of 249) with videos related to

Sort By:
Pageof 25
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 1, 1979
[Soluble complex formation of 6-ethyl-2,3,6,9-tetrahydro-3-methyl-2,9-dioxothiazolo-[5,4-f]quinoline-8-carboxylic acid (tioxacin) with aliphatic amines (author's transl)]K Uekama, F Hirayama, N Takasugi
Gan|December 1, 1970
Promotion by DNA of the photoinduced radical production from 4-nitroquinoline 1-oxide in aqueous medium at 77 degrees K and its mechanismT Okano, A Takadate, K Uekama
The Journal of Pharmacy and Pharmacology|January 1, 1996
In-vitro evaluation of biphenylyl acetic acid-beta-cyclodextrin conjugates as colon-targeting prodrugs: drug release behaviour in rat biological mediaF Hirayama, K Minami, K Uekama
The Journal of Pharmacy and Pharmacology|June 1, 1994
In-vivo and in-vitro evaluations of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcelluloses in dogsZ Wang, F Hirayama, K Uekama
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 1, 1980
[Model analyses of interfacial transfer and absorption behaviors of drugs following dissolution: approach to evaluation procedure of bioavailability (author's transl)]K Uekama, J Fujisaki, F Hirayama
Journal of Pharmaceutical Sciences|June 11, 1998
Colon-specific drug delivery based on a cyclodextrin prodrug: release behavior of biphenylylacetic acid from its cyclodextrin conjugates in rat intestinal tracts after oral administrationK Minami, F Hirayama, K Uekama
Journal of Medicinal Chemistry|August 15, 1997
6A-O-[(4-biphenylyl)acetyl]-alpha-, -beta-, and -gamma-cyclodextrins and 6A-deoxy-6A-[[(4-biphenylyl)acetyl]amino]-alpha-, -beta-, and -gamma-cyclodextrins: potential prodrugs for colon-specific deliveryK Uekama, K Minami, F Hirayama
Chemical & Pharmaceutical Bulletin|June 1, 1974
Methanesulfonic acid derivative of p,p'-diaminodiphenylsulfone. II. Pharmacokinetics and availability of parental drug in rabbitY Kurono, K Ikeda, K Uekama
Chemical & Pharmaceutical Bulletin|March 1, 1997
Varying effects of cyclodextrin derivatives on aggregation and thermal behavior of insulin in aqueous solutionK Tokihiro, T Irie, K Uekama
Pharmaceutical Research|December 1, 1994
Effect of 2-hydroxypropyl-beta-cyclodextrin on crystallization and polymorphic transition of nifedipine in solid stateF Hirayama, Z Wang, K Uekama
Pageof 25